Quality of life, prognostic and predictive factors in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Gabor Liposits^*

^*Kontaktforfatter

Publikation: Afhandling › Ph.d.-afhandling

101 Downloads (Pure)

4 Tidsskriftartikel

4 resultater

2024

The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study
Liposits, G., Winther, S. B., Ryg, J., Skuladottir, H., Möller, S., Hofsli, E., Shah, C. H., Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Osterlund, P., Glimelius, B., Sorbye, H. & Pfeiffer, P., mar. 2024, I: Journal of Geriatric Oncology. 15, 2, 4 s., 101632.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil

24 Downloads (Pure)
2023
Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study
Liposits, G., Ryg, J., Skuladottir, H., Winther, S. B., Möller, S., Hofsli, E., Shah, C. H., Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Osterlund, P., Glimelius, B., Sorbye, H. & Pfeiffer, P., jan. 2023, I: Journal of Geriatric Oncology. 14, 1, 101408.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
26 Downloads (Pure)
2022
The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6) in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy — The randomized NORDIC9-study
Liposits, G., Skuladottir, H., Ryg, J., Winther, S. B., Möller, S., Hofsli, E., Shah, C.-H., Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Osterlund, P., Johansen, J. S., Glimelius, B., Sorbye, H. & Pfeiffer, P., 23. sep. 2022, I: Journal of Clinical Medicine. 11, 19, 5603.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
35 Downloads (Pure)
2021
Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study
Liposits, G., Eshoj, H., Möller, S., Winther, S. B., Skuladottir, H., Ryg, J., Hofsli, E., Shah, C.-H., Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Österlund, P., Glimelius, B., Sorbye, H. & Pfeiffer, P., 26. maj 2021, I: Cancers. 13, 11, 17 s., 2604.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Åben adgang
Fil
46 Downloads (Pure)

Quality of life, prognostic and predictive factors in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Relaterede publikationer

Søgeresultater

The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy – The randomized NORDIC9-study

The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, dNLR, YKL-40, and IL-6) in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy — The randomized NORDIC9-study

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy—The Randomized NORDIC9-Study

The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study